To verify whether the antiviral efficacy of these two drugs is mediated through GlyRS, we treated GlyRS overexpression cells and GlyRS knockdown cells with the two drugs and measured the viral titer 24 h post-PR8 infection. The gene discussed is GARS1; the disease is infection.